Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors

被引:89
作者
Govaerts, SJ
Hermans, E
Lambert, DM
机构
[1] Univ Catholique Louvain, Ecole Pharm, Unite Chim Pharmaceut & Radiopharm, B-1200 Brussels, Belgium
[2] Univ Catholique Louvain, Lab Pharmacol Expt, B-1200 Brussels, Belgium
关键词
cannabinoid CB1 and CB2 receptors; S-35]-GTP gamma S; tetrahydrocannabinol; bicyclic cannabinoids; aminoalkylindoles; inverse agonism;
D O I
10.1016/j.ejps.2004.07.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Affinities and efficacies of several reference cannabinoid ligands were investigated at central and peripheral cannabinoid receptors in three different species (rat, mouse, and human). The tested compounds belong to different chemical classes such as classical and non-ciassical terpene derivatives (Delta(8)-THC, Delta(9)-THC, HU 210, CP 55,940, CP 55,244, CP 55,243 and CP 47,947), aminoalkylindole (WIN 55,212-2, WIN 55,212-3) and diarylpyrazole cannabinoids (SR 141716A, SR 144528). As cannabinoid receptors have been shown to be mainly coupled to Gi/o type G- proteins, and by using the [S-35]-GTPgammaS nucleotide binding modulation, we characterized the functional activity of these ligands which can act as agonists (positive intrinsic activity), partial agonists (partial positive intrinsic activity), antagonists (no intrinsic activity), or inverse agonists (negative intrinsic activity). To our knowledge, some derivatives (Delta(8)-THC, WIN 55,212-3, CP 55,243 and CP 47,947) have never been characterized in [S-35]-GTPgammaS binding assays and up to now, this study represents the largest survey of reference cannabinoids performed in unique experimental conditions and in the same laboratory. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:233 / 243
页数:11
相关论文
共 42 条
  • [1] THE PERIPHERAL CANNABINOID RECEPTOR - ADENYLATE-CYCLASE INHIBITION AND G-PROTEIN COUPLING
    BAYEWITCH, M
    AVIDORREISS, T
    LEVY, R
    BARG, J
    MECHOULAM, R
    VOGEL, Z
    [J]. FEBS LETTERS, 1995, 375 (1-2) : 143 - 147
  • [2] (-)-Delta(9)-Tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase
    Bayewitch, M
    Rhee, RH
    AvidorReiss, T
    Breuer, A
    Mechoulam, R
    Vogel, Z
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) : 9902 - 9905
  • [3] Changes in cannabinoid CB1 receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis
    Berrendero, F
    Sánchez, A
    Cabranes, A
    Puerta, C
    Ramos, JA
    García-Merino, A
    Fernández-Ruiz, J
    [J]. SYNAPSE, 2001, 41 (03) : 195 - 202
  • [4] A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1 - Evidence for a new model of receptor/ligand interactions
    Bouaboula, M
    Perrachon, S
    Milligan, L
    Canat, X
    RinaldiCarmona, M
    Portier, M
    Barth, F
    Calandra, B
    Pecceu, F
    Lupker, J
    Maffrand, JP
    LeFur, G
    Casellas, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) : 22330 - 22339
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] Breivogel CS, 2000, J PHARMACOL EXP THER, V295, P328
  • [7] Cannabinoid receptor agonist efficacy for stimulating [35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity
    Breivogel, CS
    Selley, DE
    Childers, SR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) : 16865 - 16873
  • [8] Cloning and molecular characterization of the rat CB2 cannabinoid receptor
    Brown, SM
    Wager-Miller, J
    Mackie, K
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2002, 1576 (03): : 255 - 264
  • [9] Delta(9)-tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain
    Burkey, TH
    Quock, RM
    Consroe, P
    Roeske, WR
    Yamamura, HI
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 323 (2-3) : R3 - R4
  • [10] Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain
    Burkey, TH
    Quock, RM
    Consroe, P
    Ehlert, FJ
    Hosohata, Y
    Roeske, WR
    Yamamura, HI
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 336 (2-3) : 295 - 298